161 related articles for article (PubMed ID: 38709790)
1. Toll-like receptors 1-9 in small bowel neuroendocrine tumors-Clinical significance and prognosis.
Hiltunen N; Kemi N; Väyrynen JP; Böhm J; Kauppila JH; Huhta H; Helminen O
PLoS One; 2024; 19(5):e0302813. PubMed ID: 38709790
[TBL] [Abstract][Full Text] [Related]
2. CD3
Hiltunen N; Väyrynen JP; Böhm J; Helminen O
Diseases; 2021 Jun; 9(2):. PubMed ID: 34208144
[TBL] [Abstract][Full Text] [Related]
3. Monocarboxylate Transporters 1 and 4 and Prognosis in Small Bowel Neuroendocrine Tumors.
Hiltunen N; Rintala J; Väyrynen JP; Böhm J; Karttunen TJ; Huhta H; Helminen O
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626155
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Role of Lymph Node Positivity and Number of Lymph Nodes Needed for Accurately Staging Small-Bowel Neuroendocrine Tumors.
Zaidi MY; Lopez-Aguiar AG; Dillhoff M; Beal E; Poultsides G; Makris E; Rocha F; Crown A; Idrees K; Marincola Smith P; Nathan H; Beems M; Abbott D; Barrett JR; Fields RC; Davidson J; Cardona K; Maithel SK
JAMA Surg; 2019 Feb; 154(2):134-140. PubMed ID: 30383112
[TBL] [Abstract][Full Text] [Related]
5. Mesenteric Tumor Deposits in Midgut Small Intestinal Neuroendocrine Tumors Are a Stronger Indicator Than Lymph Node Metastasis for Liver Metastasis and Poor Prognosis.
Fata CR; Gonzalez RS; Liu E; Cates JM; Shi C
Am J Surg Pathol; 2017 Jan; 41(1):128-133. PubMed ID: 27684993
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and prognostic significance of extramural venous invasion in neuroendocrine tumors of the small intestine.
Liu Q; Polydorides AD
Mod Pathol; 2020 Nov; 33(11):2318-2329. PubMed ID: 32514164
[TBL] [Abstract][Full Text] [Related]
7. Surgical Management of Small Bowel Neuroendocrine Tumors: Specific Requirements and Their Impact on Staging and Prognosis.
Pasquer A; Walter T; Hervieu V; Forestier J; Scoazec JY; Lombard-Bohas C; Poncet G
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S742-9. PubMed ID: 26014153
[TBL] [Abstract][Full Text] [Related]
8. The Lymph Node Ratio Optimizes Staging in Patients with Small Intestinal Neuroendocrine Tumors.
Wu L; Chen F; Chen S; Wang L
Neuroendocrinology; 2018; 107(3):209-217. PubMed ID: 29920478
[TBL] [Abstract][Full Text] [Related]
9. Revised staging classification improves outcome prediction for small intestinal neuroendocrine tumors.
Kim MK; Warner RR; Roayaie S; Harpaz N; Ward SC; Itzkowitz S; Wisnivesky JP
J Clin Oncol; 2013 Oct; 31(30):3776-81. PubMed ID: 24043726
[TBL] [Abstract][Full Text] [Related]
10. The Pancreas as a Site of Metastasis or Second Primary in Patients with Small Bowel Neuroendocrine Tumors.
Scott AT; Pelletier D; Maxwell JE; Sherman SK; Keck KJ; Li G; Dillon JS; O'Dorisio TM; Bellizzi AM; Howe JR
Ann Surg Oncol; 2019 Aug; 26(8):2525-2532. PubMed ID: 31011904
[TBL] [Abstract][Full Text] [Related]
11. Extent of Lymph Node Dissection for Small Bowel Neuroendocrine Tumors.
Hallet J; Law C;
World J Surg; 2021 Jan; 45(1):197-202. PubMed ID: 32737557
[TBL] [Abstract][Full Text] [Related]
12. HSP90 expression and early recurrence in gastroenteropancreatic neuroendocrine tumors: Potential for a novel therapeutic target.
Gamboa AC; Ethun CG; Postlewait LM; Lopez-Aguiar AG; Zhelnin K; Krasinskas A; El-Rayes BF; Russell MC; Kooby DA; Staley CA; Cardona K; Maithel SK
Surg Oncol; 2020 Dec; 35():460-465. PubMed ID: 33080545
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center.
Norlén O; Stålberg P; Öberg K; Eriksson J; Hedberg J; Hessman O; Janson ET; Hellman P; Åkerström G
World J Surg; 2012 Jun; 36(6):1419-31. PubMed ID: 21984144
[TBL] [Abstract][Full Text] [Related]
14. Melatonin Immunoreactivity in Malignant Small Intestinal Neuroendocrine Tumours.
Söderquist F; Janson ET; Rasmusson AJ; Ali A; Stridsberg M; Cunningham JL
PLoS One; 2016; 11(10):e0164354. PubMed ID: 27736994
[TBL] [Abstract][Full Text] [Related]
15. IMP3 expression in small-intestine neuroendocrine neoplasms: a new predictor of recurrence.
Massironi S; Del Gobbo A; Cavalcoli F; Fiori S; Conte D; Pellegrinelli A; Milione M; Ferrero S
Endocrine; 2017 Nov; 58(2):360-367. PubMed ID: 28210937
[TBL] [Abstract][Full Text] [Related]
16. The Added Diagnostic Value of
Addeo P; Poncet G; Goichot B; Leclerc L; Brigand C; Mutter D; Romain B; Namer IJ; Bachellier P; Imperiale A
J Gastrointest Surg; 2018 Apr; 22(4):722-730. PubMed ID: 29235002
[TBL] [Abstract][Full Text] [Related]
17. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of lymph node metastases in small intestinal neuroendocrine tumors.
Kim MK; Warner RR; Ward SC; Harpaz N; Roayaie S; Schwartz ME; Itzkowitz S; Wisnivesky J
Neuroendocrinology; 2015; 101(1):58-65. PubMed ID: 25572143
[TBL] [Abstract][Full Text] [Related]
19. High VEGF serum values are associated with locoregional spread of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Cigrovski Berković M; Čačev T; Catela Ivković T; Marout J; Ulamec M; Zjačić-Rotkvić V; Kapitanović S
Mol Cell Endocrinol; 2016 Apr; 425():61-8. PubMed ID: 26805636
[TBL] [Abstract][Full Text] [Related]
20. Relevant prognostic factors in patients with stage IV small intestine neuroendocrine neoplasms.
Maurer E; Heinzel-Gutenbrunner M; Rinke A; Rütz J; Holzer K; Figiel J; Luster M; Bartsch DK
J Neuroendocrinol; 2022 Jan; 34(1):e13076. PubMed ID: 34964186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]